Key Takeaways
- Earnings normalized after a one-off Q2 boost: Q3 profitability stepped down from Q2, which had included a ~₹100 crores dividend receipt, but management expects Q4 to hold at Q3’s level and comfortably beat the weak ~₹25 crores profit of Q4 last year.
- Volume-led strategy is working through subsidy headwinds: Fertilizer output and sales volumes rose on higher capacity utilization, offsetting lower P&K subsidy rates and negative-margin DAP imports of 1.27 lakh metric tons.
- Industrial products face a margin squeeze: The caprolactam segment is under pressure from a declining capro-benzene spread (down from $674 to $588 per metric ton YoY), though management says only a small pricing improvement is needed to reach breakeven.
- Capex cycle is nearing its first completions: The Urea-II revamp, Sulphuric Acid V plant, and solar projects are all expected to be capitalized by March or the first half of next year, promising permanent cost reductions and new market sales.
- What to watch next quarter: Whether Q4 fertilizer sales hit the 3–3.25 lakh metric ton target, the pace of commissioning for the three near-completion capex projects, and any movement on the repeatedly deferred corporate action decision now pushed to ’26.
Profitability Drivers & Headwinds
- Q2-to-Q3 step-down explained: Q2 profitability was inflated by a ~₹100 crores dividend receipt that did not recur in Q3, making the sequential decline a normalization rather than an operational deterioration.
- Q4 profit outlook: Management expects Q4 profitability to remain similar to Q3, which would represent a sharp improvement over the ~₹25 crores profit reported in Q4 of the prior year.
- Natural gas tailwind: A 10% YoY reduction in natural gas prices in Q3 provided some relief against rising raw material costs.
- Caprolactam margin pressure: The capro-benzene spread declined from $674 to $588 per metric ton YoY, squeezing profitability in the caprolactam segment. Mitigation steps include importing cheaper Anone to replace production from the old Anone-1 plant and diverting HX to the HX Sulphate plant, but the segment remains largely dependent on international benzene and caprolactam pricing.
- DAP imports are a zero-margin necessity: The company imported 1.27 lakh metric tons of DAP at ₹758 crores because domestic production economics are negative; these imports provided no margin.
Bajpai: "Till the time we have the positive contribution, we will continue the production."
Fertilizer Operations & Volume Strategy
- Volume growth offset subsidy pressure: P&K fertilizer subsidy rates were lower on a 9-month YoY basis, but the company boosted production and sales volume to navigate the headwind.
- Capacity utilization drove output: Fertilizer output and sales volume increased due to higher capacity utilization at the APS Sikka Unit and ammonium sulphate at the HO/Vadodara Unit. Urea output was lower in Q3 versus Q2 due to availability constraints from the government side.
- Q4 sales target set: Management targets booking sales of 3 lakh to 3.25 lakh metric tons in Q4, with limited stock strategically placed in the market.
- Discount risk contained: No discounts are foreseen in Q4; shutdowns have been taken during the lean season for urea, APS, and ammonium sulphate plants, keeping inventory tight.
- Sulphuric acid self-sufficiency: The Vadodara Unit’s sulphuric acid requirement for ammonium sulphate is met by its own competitive production, insulating ammonium sulphate and APS production from any market price increases.
Bajpai: "No, in the quarter 4, I don't foresee any discounts will be there. So we have the limited stock and that has been strategically placed in the market."
Capex Projects & Commissioning Timeline
- Three projects nearing the finish line: The Urea-II Revamping project, Sulphuric Acid V plant (1,98,000 tpa), and solar power projects are all expected to be capitalized by March or the first half of the next financial year.
- Urea-II revamp delivers permanent cost savings: The project will reduce energy consumption from ~6.5 Gcal/metric ton to ~5.8–5.85 Gcal/metric ton, meeting government energy norms. Each 0.5 kilocalorie reduction in the energy norm cuts costs by ₹30–35 crores annually, a permanent and continuous benefit.
- Sulphuric Acid V opens a new revenue stream: After capitalization, the plant will allow captive consumption plus roughly 40% of production available for market sale at good margins.
- Solar power replaces costly grid electricity: The Charanka solar plant (15 MW) at ₹3–4/unit and the GIPCL solar plant (37.5 MW share) at ₹4–5/unit will replace power purchased at ₹8–9/unit from GEB. The GIPCL 75 MW plant is expected in the first half of the next financial year.
- Near-term capex spend: Of the ₹500 crores capex, ₹200 crores will be spent by March and the remaining ₹300 crores in the next quarter or first half of the next year. This does not include the larger ₹1,500 crores Sikka phosphoric acid/sulphuric acid plant, which remains in the detailed engineering stage with no timeline given.
- HX plant stabilized: The new HX plant, commissioned in October 2024, has stabilized at its rated capacity of 20 metric tons per day and sometimes surpasses 100% capacity. Profitability is comfortable, though exact numbers were not shared given the early stage.
Industrial Products & Demand Outlook
- Demand stable, pricing under threat: Industrial products demand is likely to remain stable to firm in the next quarter, but pricing may be affected by cheap Chinese imports.
- Caprolactam near breakeven: Management stated that only a small improvement in caprolactam pricing will suffice to reach breakeven, suggesting the segment is operating close to the margin line.
- Cost mitigation through product mix: Cost pressures across the portfolio were mitigated by optimizing the product mix toward more profitable fertilizers and industrial products and by increasing capacity utilization.
Corporate Actions & Governance
- Decision deferred again to ’26: Management stated that after current expansion plans are executed over the next year or so, the Board will decide on suitable corporate actions (bonus, buyback) in the year ’26. A Gujarat government circular on the matter exists, but no specific timeline was offered.
- Investor frustration acknowledged: When pressed on the repeated deferral, with one analyst noting the same answer had been given for two years, management personally assured the analyst that the concern would be taken to top management and the Board.
Bajpai: "This is not what I can say you and this is beyond my authority. It is ultimately the Board and the Gujarat Government Chief Secretary is our Chairman. So they will take the appropriate action."
Raw Material Sourcing
- Rock phosphate sourcing progressing: The executive team, along with the MD, visited Dubai to source rock phosphate and spoke to Jordan Rock Phosphate and other major suppliers. Management is hopeful of availability and expects no problem securing supply, though no agreement has been executed yet.
- Phosphoric acid requirements: The Vadodara unit has its own phosphoric acid plant; the Sikka unit needs a new plant to be established, which is part of the ₹1,500 crores project still in detailed engineering.
Bajpai: "Yes, yes, we are scouting for this rock phosphate, and we have made a visit, our executive team along with our MD, visited Dubai to source that and Jordan Rock Phosphate and other suppliers, the major suppliers we have spoken to. And we are quite hopeful rock phosphate availability is certain and there will not be any problem."
Guidance & Commitments
| Commitment | Specifics | Timeline |
|---|---|---|
| Q4 fertilizer sales volume | Book sales of 3 lakh to 3.25 lakh metric tons | Q4 FY25 |
| Q4 profitability | Profitability to remain same as Q3; better than ~₹25 crores profit in Q4 last year | Q4 FY25 |
| Urea-II Revamping commissioning | Energy consumption reduced to ~5.8–5.85 Gcal/metric ton, meeting government norms | Coming quarter (Q4 FY25) |
| Sulphuric Acid V plant capitalization | 1,98,000 tpa plant operational; 40% surplus for market sale | By first half of next financial year |
| Solar projects capitalization | Charanka (15 MW) and GIPCL (37.5 MW share) replacing ₹8–9/unit grid power | Charanka by March; GIPCL in H1 next financial year |
| Near-term capex spend | ₹200 crores by March, ₹300 crores in Q1 or H1 next year | March and H1 next financial year |
| Corporate action decision | Board to decide on bonus/buyback after current capex plans executed | Year ’26 |
Key Metrics
| Metric | Q3 FY25 |
|---|---|
| Consolidated revenue growth | 40% YoY |
| Consolidated PBT growth | 16% YoY |
| Consolidated PAT growth | 13% YoY |
| Standalone 9-month PBT growth | 3% YoY |
| Standalone 9-month PAT growth | 2% YoY |
| Fertilizer output | ~77,000 metric tons, up 23% YoY |
| Fertilizer sales volume | 1.254 lakh metric tons, up 25% YoY |
| DAP imported | 1.27 lakh metric tons, at ~₹758 crores, no margin contribution |
| Capro-benzene spread | $588 per metric ton, down from $674 per metric ton in Q3 last year |
| Natural gas price reduction | 10% YoY in Q3 |
| Q4 FY25 sales volume target | 3 lakh to 3.25 lakh metric tons |
| Subsidy status | Imported P&K received up to Dec '24; indigenous P&K up to second week of Jan '25; urea up to third week of Jan '25 |
| EPS (as on 31st Dec '24) | ₹13.03 |
| Annualized 9-month EPS | ₹17.22 |
| Investments | ~₹7,000 crores |
| Cash and bank balance | ₹2,500 crores |